SAM Nordic attended the THINK-meeting (THeragnostic International NetworK) in Madrid to learn more about diagnosis and treatment of neuroendocrine tumors (NETs) using nuclear medicine techniques developed in recent years
In picture from left: Laura Ravasi, Advanced Accelerator Applications, Annette Andrén, SAM Nordic, Malle Paris, from Estland, Mette Møller Jørgensen, Rigshospitalet, Johanna Dalmo, Sahlgrenska University Hospital and Jennie Nordin, Skånes universitetssjukhus (Skåne University Hospital)